Increase in plasma levels of clozapine after addition of isoniazid

Journal of Clinical Psychopharmacology

Volumn 29, Issue 2, 2009, Pages 190-191

  Angelini, Michael C ^a   MacCormack Gagnon, Jacqueline ^b   Dizio, Stephen ^c  

^a MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^c East Bay Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; DOCUSATE SODIUM; ISONIAZID; MAGNESIUM HYDROXIDE; METOPROLOL; NORCLOZAPINE; VENLAFAXINE;

AGED; ANEMIA; BEDTIME DOSAGE; CASE REPORT; CONSTIPATION; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; GENERALIZED ANXIETY DISORDER; HUMAN; HYPERTENSION; LETTER; MALE; MORNING DOSAGE; PRIORITY JOURNAL; SCHIZOPHRENIA; SOCIAL PHOBIA; TUBERCULOSIS;

AGED; ANTIPSYCHOTIC AGENTS; ANTITUBERCULAR AGENTS; CLOZAPINE; DRUG INTERACTIONS; HUMANS; ISONIAZID; MALE; SCHIZOPHRENIA, PARANOID; TUBERCULOSIS;

EID: 67649351932     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31819a6b53     Document Type: Letter

References (11)

1. Chetty M, Murray M. CYP-mediated clozapine interactions: how predictable are they? Curr Drug Metab. 2007;8: 307-313.
2. Eiermann B, Engel G, Johansson I, et al. The involvement of CYP 1A2 and CYP 3A4 in the metabolism of clozapine. Br J Clin Pharmacol. 1997;44:39-446.
3. Herringa M, Beurskens W, Schouten W, et al. Elevated plasma levels of clozapine after concomitant use of fluvoxamine. Pharm World Sci. 1999;21:243-244.
4. Raaska K, Neuvonem P. Ciprofloxacin increases serum clozapine and N-desmethylclozapine: a study in patients with schizophrenia. Eur J Clin Pharmacol. 2000;56:585-589.
5. Polasek T, Elliot D, Somogyi A, et al. An evaluation of potential mechanism-based inactivation of human drug metabolizing cytochromes P450 by monoamine oxidase inhibitors, including isoniazid. Br J Clin Pharmacol. 2006;61:570-584.
6. Self T, Chrisman C, Baciewicz A, et al. Isoniazid drug and food interactions. Am J Med Sci. 1999;317:304-311.
7. Wen X, Wang J, Neuvonen PJ, et al. Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes. Eur J Clin Pharmacol. 2002;57:599-804.
8. Isoniazid. In: Klasco RK, ed. DRUGDEX® System [edition expires 2008]. Greenwood Village, CO: Thomson Micromedex. Available at: http://www.thomsonhc.com/. Accessed 3/12/2008.
9. Bell R, McLaren A, Galanos J, et al. The clinical use of plasma clozapine levels. Aust N Z J Psychiatry. 1998;32:567-574.
10. DiMartini A. Isoniazid tricyclics and the 'cheese reaction'. Int Clin Psychopharm. 1995;10:197-198.
11. Moore TJ, Cohen MR, Furberg CD. Serious adverse drug events reported to the food and drug administration, 1998-2005. Arch Intern Med. 2007;167:1752-1759.